glp 1 stories GLP-1 are often told through the lens of weight loss. But Health's new survey suggests that, for many users, changes go far beyond the number on the scale. 📸 Getty/David Petrus What should you know before

GHK-Cu is a naturally occurring copper-binding tripeptide studied in laboratory environments for its interaction with extracellular matrix signaling pathways, copper transport activity, and peptide-mediated gene expression models

Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)which is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonisthave gained widespread attention for their effectiveness in treating obesity and type 2 diabetes

The company emphasizes their product as first-to-market holistic natural GLP support

As peptide-based molecules, GLP-1 agonists are relatively large and do not readily diffuse across the BBB